Vascular Access Device Market Size, Share & Trends Analysis Report By Product Type (Central Vascular Access Devices, Peripheral Vascular Access Devices, Intraosseous Vascular Access Devices, Accessories), By Application (Drug Administration, Fluid & Nutrient Administration, Blood Transfusion, Diagnostics & Testing, Hemodialysis, Chemotherapy, Anesthesia, IV Fluids), By End User (Hospitals, Clinics & Ambulatory Care Centres, Long-Term Care Facilities, Home Healthcare Settings), By Material (Polyurethane, Polyethylene, Teflon, Silicone), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Vascular Access Device Market Size

The global vascular access device market size was valued at USD 6.12 billion in 2025 and is projected to grow from USD 6.55 billion in 2026 to USD 11.24 billion by 2034, registering a CAGR of 6.99% during the forecast period from 2026 to 2034. North America dominated the vascular access device market with a market share of 38.6% in 2025.

The global vascular access device market is experiencing significant growth, driven by the increasing prevalence of chronic diseases such as cancer, diabetes, and end-stage renal disease (ESRD). The rising geriatric population, more susceptible to these conditions, further fuels the demand for vascular access devices. Technological advancements, including the integration of antimicrobial coatings and real-time imaging guidance, enhance the safety and efficacy of these devices, promoting their adoption in clinical settings.

Moreover, the shift towards minimally invasive procedures and expanding home healthcare services contributes to market growth. However, challenges like the risk of catheter-related bloodstream infections (CRBSIs) and the high cost of advanced devices may hinder market expansion. Nonetheless, ongoing research and development efforts to improve device design and functionality are expected to create new opportunities in the market.

Product Type Insights

Central Vascular Access Devices (CVADs) dominate the market due to their extensive use in long-term intravenous therapies such as chemotherapy, parenteral nutrition, and hemodialysis. The increasing prevalence of chronic diseases necessitating prolonged treatment regimens has propelled the demand for CVADs. Furthermore, advancements in catheter materials and insertion techniques have improved patient outcomes and reduced complications, reinforcing the preference for CVADs in clinical settings. The integration of ultrasound-guided insertion methods has enhanced the safety and efficacy of CVAD placement, contributing to their widespread adoption. As healthcare providers prioritise patient comfort and treatment efficiency, the demand for CVADs is expected to maintain its upward trajectory.

Request Customizationto receive a tailored report.

Application Insights

Drug administration is the leading application segment in the market, driven by the necessity for efficient and reliable delivery of medications in various therapeutic areas. Vascular access devices facilitate the administration of chemotherapeutic agents, antibiotics, analgesics, and other critical medications, ensuring rapid onset of action and optimal therapeutic outcomes. The growing incidence of chronic diseases, such as cancer and cardiovascular disorders, has intensified the need for long-term intravenous drug delivery systems. Moreover, the shift towards outpatient care and home-based infusion therapies has further amplified the demand for user-friendly vascular access solutions, propelling the growth of this application segment.

End User Insights

Hospitals represent the largest end-user segment in the market, attributed to the high volume of surgical procedures, emergency admissions, and inpatient treatments requiring vascular access. The presence of skilled healthcare professionals and advanced medical infrastructure in hospital settings ensures the safe insertion and management of vascular access devices. Additionally, hospitals often serve as primary centres for administering complex therapies, such as chemotherapy and dialysis, necessitating central and peripheral vascular access devices. Collaborations between hospitals and government bodies for disease awareness campaigns and funding programs have also contributed to the expansion of this segment.

Material Insights

Polyurethane has emerged as the dominant material in the market, owing to its favourable properties such as biocompatibility, flexibility, and durability. These characteristics make polyurethane an ideal choice for manufacturing catheters that can withstand prolonged use without causing irritation or adverse reactions. The material's versatility allows for producing devices suitable for various applications, including central and peripheral vascular access. Furthermore, polyurethane's cost-effectiveness and ease of manufacturing have encouraged its widespread adoption among medical device manufacturers. As the demand for long-term vascular access solutions continues to rise, the preference for polyurethane-based devices is expected to persist, driving the growth of this material segment.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds the largest share of the global vascular access device market, driven by advanced healthcare infrastructure, high prevalence of chronic diseases, and significant investments in research and development. The United States, in particular, contributes substantially to this dominance, with a large patient population requiring vascular access for treatments such as chemotherapy, dialysis, and long-term medication administration. According to the National Cancer Institute, approximately 2,001,140 new cancer cases were projected in the U.S. in 2024, indicating a substantial demand for vascular access devices. The presence of key market players and continuous technological advancements have also contributed to the region's leading position in the market.

U.S. Vascular Access Device Market Trend

• The United States is the largest and most mature market for vascular access devices, fueled by a high prevalence of chronic illnesses such as cancer, kidney disease, and diabetes. Advanced healthcare infrastructure, favourable reimbursement policies, and widespread adoption of new technologies ensure robust demand. The presence of key players like BD, Teleflex, and ICU Medical, along with heavy R&D investments, further strengthens the market. Regulatory bodies like the FDA support innovation in device safety and efficiency, while the shift toward home healthcare and outpatient services continues to expand opportunities for vascular access solutions.
• Canada’s vascular access device market is experiencing steady growth, supported by a strong public healthcare system, an ageing population, and government efforts to minimise hospital-acquired infections. The country’s emphasis on preventive care and chronic disease management has increased the adoption of advanced vascular access devices with antimicrobial coatings and safety features. Supportive policies by Health Canada and growing partnerships with device manufacturers enhance access to innovative medical technologies. Additionally, collaborations with provincial health authorities to improve patient safety outcomes further contribute to expanding this market.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Vascular Access Device Market Trend

The Asia-Pacific region is poised to experience the fastest growth in the market for vascular access device, driven by expanding healthcare infrastructure, increasing healthcare expenditure, and a rising burden of chronic diseases. Countries like China, India, and Japan are witnessing a surge in demand for vascular access devices due to their large populations and growing prevalence of conditions requiring long-term intravenous therapies. Furthermore, government initiatives to improve healthcare access and invest in medical infrastructure have created a conducive environment for market growth. The increasing adoption of home-based healthcare services and the rising awareness of advanced medical treatments are also contributing to the rapid expansion of the vascular access device market in the Asia-Pacific region.

• China represents one of the fastest-growing markets for vascular access devices due to its expanding middle class, rising chronic disease prevalence, and government healthcare reforms. The “Healthy China 2030” initiative aims to modernise healthcare infrastructure, pushing hospitals and clinics to adopt advanced medical technologies. Domestic and international manufacturers are increasing investments to localise production and meet growing demand. The surge in chemotherapy, dialysis, and infusion therapies has necessitated more efficient and safer vascular access solutions. China’s growing private hospital network and telemedicine expansion are accelerating adoption, especially in urban centres.
• India’s vascular access device market is expanding rapidly, driven by rising healthcare awareness, increasing patient volumes, and government programs like Ayushman Bharat aimed at improving access to quality care. With a growing burden of non-communicable diseases, especially cancer and kidney failure, the need for long-term intravenous therapies is surging. Public-private partnerships and foreign investments enhance device availability across urban and semi-urban areas. The growth of medical tourism and the shift toward day-care procedures and home infusion therapies also support increased use of vascular access devices in public and private hospitals.

Europe Vascular Access Device Market Trend

Europe represents a significant market for vascular access device, characterised by a well-established healthcare system, increasing healthcare expenditure, and a growing ageing population. Countries such as Germany, the United Kingdom, and France are at the forefront of market growth, driven by the rising incidence of chronic diseases and the adoption of advanced medical technologies. Government initiatives to improve healthcare infrastructure and promote early disease detection have further fueled the demand for vascular access devices in the region. Additionally, collaborations between European healthcare institutions and medical device manufacturers have facilitated the development and adoption of innovative vascular access technologies.

• The United Kingdom is witnessing a rising demand for vascular access devices due to its ageing population and the growing burden of chronic diseases. NHS-led initiatives focusing on reducing hospital stays and promoting home-based care are increasing the need for reliable, long-term vascular access. The adoption of minimally invasive techniques and safer insertion technologies has gained traction in clinical settings. Furthermore, investments in digital health and medical innovation are encouraging market growth. Collaborations between public hospitals and private players enhance accessibility to cutting-edge vascular solutions.
• Germany remains a leading market for vascular access devices in Europe, supported by one of the world’s most advanced healthcare systems. The country's high focus on patient safety, early disease detection, and healthcare digitisation fosters demand for high-quality vascular access technologies. Germany’s industrial strength and homegrown medtech companies, such as B. Braun and Fresenius, contribute to robust domestic manufacturing and innovation. The national emphasis on integrating antimicrobial and biocompatible materials into vascular devices supports infection prevention efforts, a major driver amid the rise of hospital-acquired complications.

Company Market Share

The global vascular access device market is highly competitive, with several key players striving to maintain their market positions through product innovation, strategic partnerships, and mergers and acquisitions. Companies focus on developing advanced vascular access devices that improve patient outcomes and reduce complications. The competitive landscape is characterised by the presence of both established players and emerging companies, contributing to the market's dynamic nature.

Becton, Dickinson and Company (BD): Becton, Dickinson and Company (BD) maintains its dominant position in the global market. The company's strong geographic presence across 61 countries and a comprehensive product portfolio contribute to its market leadership. BD's commitment to research and development has led to the introduction of innovative vascular access devices, enhancing patient outcomes and safety. The company's strategic acquisitions, such as the acquisition of C.R. Bard in 2017, have further strengthened its market position.

List of Key and Emerging Players in Vascular Access Device Market